论文部分内容阅读
目的观察特拉唑嗪对高血压合并2型糖尿病的疗效。方法选择确诊的高血压病3级合并2型糖尿病患者,在应用厄贝沙坦片和氨氯地平治疗血压不达标的患者,随机分为2组,对照组加用比索洛尔2.5～5mg或氢氯塞嗪12.5mg1次/d口服;治疗组加用特拉唑嗪片2～4mg每晚一次口服。疗程观察15d。结果治疗组血压达标且对糖代谢无明显影响,结果差异有统计学意义。结论特拉唑嗪对高血压病3级合并2型糖尿病的治疗结果是血压达标且对糖代谢无明显影响。
Objective To observe the curative effect of terazosin on type 2 diabetes mellitus patients with hypertension. Methods Selected patients with type 3 diabetes mellitus complicated with type 2 diabetes mellitus diagnosed as hypertension were randomly divided into two groups. The patients in control group were treated with bisoprolol 2.5-5 mg or Hydrochlorothiazide 12.5mg1 times / d orally; the treatment group plus terazosin tablets 2 ~ 4mg once a night orally. Treatment observation 15d. Results In the treatment group, the blood pressure reached the standard and had no significant effect on the glucose metabolism. The difference was statistically significant. Conclusion Terazosin for hypertension grade 3 with type 2 diabetes treatment results are blood pressure compliance and no significant effect on glucose metabolism.